Clinical trial
Optimizing IFN Beta - 1B Dose
NCT00473213 · University of Turin, Italy, Other · Completed
Key facts
| NCT number | NCT00473213 |
|---|---|
| Title | Optimizing IFN Beta - 1B Dose |
| Official title | Optimizing IFN Beta - 1B Dose |
| Acronym | Optims |
| Lead sponsor | University of Turin, Italy, Other |
| Collaborators | Dimensione Ricerca s.r.l. |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Interferon Beta 1 |
| Enrollment | 217 |
| Start date | Sep 1, 1999 |
| Completion | Feb 1, 2004 |
| First posted | May 14, 2007 |
| Last update posted | May 14, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: